Search Results - Kai Duan

Development of Nasal Vaccines and the Associated Challenges by Xuanxuan Nian, Jiayou Zhang, Shihe Huang, Kai Duan, Xinguo Li, Xiaoming Yang

Connect to this object online.

Suspended cell lines for inactivated virus vaccine production by Jiayou Zhang, Zhenyu Qiu, Siya Wang, Zhenbin Liu, Ziling Qiao, Jiamin Wang, Kai Duan, Xuanxuan Nian, Zhongren Ma, Xiaoming Yang

Connect to this object online.

Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study by Renfeng Fan, Xiaoyuan Huang, Xuanxuan Nian, Zhiqiang Ou, Jian Zhou, Jiayou Zhang, Peiyu Zeng, Wei Zhao, Jinglong Deng, Wei Chen, Shaomin Chen, Kai Duan, Yingshi Chen, Xinguo Li, Jikai Zhang, Xiaoming Yang

Connect to this object online.

Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine：a phase I clinical trial by Zhi-Wei Wu, Qing-Liang Li, Hai-Song Zhou, Kai Duan, Zhao Gao, Xin-Jiang Zhang, Zhi-Jun Jiang, Zhi-Yong Hao, Fei Jin, Xuan Bai, Qi Li, Ge-Lin Xu, Yu-Liang Zhao, Xiao-Ming Yang

Connect to this object online.

Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority... by Xiaoyuan Huang, Ting Fan, Li Li, Xuanxuan Nian, Jiayou Zhang, Xuefen Gao, Wei Zhao, Wei Chen, Zhaoqing Zhang, Zhihao Yao, Xixin Han, Jinrong Shi, Ying Wang, Haihe Bian, Nianmin Shi, Xinguo Li, Kai Duan, Guohua Li, Xiaoming Yang

Connect to this object online.

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical study by Xiaoyuan Huang, Jing Liang, Lili Huang, Xuanxuan Nian, Wei Chen, Jiayou Zhang, Xiao Xu, Xuan Lin, Yue Wang, Jinrong Shi, Lanxin Jia, Qingliang Li, Qianxi Wang, Kai Duan, Xinguo Li, Yaqi Ji, Feixia Peng, Wei Zhang, Zhiqiang Xie, Yanxia Wang, Xiaoming Yang

Connect to this object online.

Clinical evaluation of the lot-to-lot consistency of an enterovirus 71 vaccine in a commercial-scale phase IV clinical trial by Jinhua Chen, Pengfei Jin, Xiaoqi Chen, Qunying Mao, Fanyue Meng, Xinguo Li, Wei Chen, Meizhi Du, Fan Gao, Pei Liu, Xiujuan Li, Changfu Guo, Tingbo Xie, Weiwei Lu, Qingliang Li, Li Li, Xing Yan, Xiang Guo, Hongqiao Du, Xiuling Li, Kai Duan, Fengcai Zhu

Connect to this object online.

Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial by Zhi-Wei Wu, Fei Jin, Qing-Liang Li, Jia-Mei Gao, Hai-Song Zhou, Kai Duan, Zhao Gao, Yan Liu, Zhi-Yong Hao, Wei Chen, Yue-Yue Liu, Ge-Lin Xu, Biao Yang, Ben Dong, Jiu-Wei Zhang, Yu-Liang Zhao, Xiao-Ming Yang

Connect to this object online.